Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Phase Holographic Imaging PHI

0,66 SEK

-2,64 %

Mindre end 1K følgere

PHI

Spotlight Stock Market

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
-2,64 %
-29,51 %
-43,00 %
-45,80 %
-59,51 %
-63,31 %
-72,33 %
-97,54 %
-95,32 %

PHI is active in medical technology and develops both hardware and software for quantitative analysis of living cell cultures. The HoloMonitor® products are based on non-invasive QPI technology that collects data on cell quality and are sold globally through distributors with a focus on preclinical cancer research, stem cell research and drug development. Going forward, PHI focuses on developing its products for the clinical market and in regenerative medicine. PHI has offices in Lund, Boston, and Winston-Salem.

Læs mere
Markedsværdi
41,87 mio. SEK
Aktieomsætning
13,73 t SEK
Omsætning
16,65 mio.
EBIT %
-89,79 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
19.12
2025

Delårsrapport Q2'26

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelsei går

BioStock: PHI advances its IVF focus with HoloOocyte

Phase Holographic Imaging PHI
Pressemeddelelse15.10.2025, 08.45

BioStock: PHI comments on expansion into veterinary IVF

Phase Holographic Imaging PHI
Selskabsmeddelelse14.10.2025, 09.35

Phase Holographic: PHI sets sights on IVF applications in livestock

Phase Holographic Imaging PHI

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse1.10.2025, 08.02

BioStock: PHI gears up for next-gen launch after strong year

Phase Holographic Imaging PHI
Selskabsmeddelelse26.9.2025, 15.24

Rättelse 2: Phase Holographic: Annual Report 2024/2

Phase Holographic Imaging PHI
Selskabsmeddelelse26.9.2025, 10.12

Rättelse: Phase Holographic: Annual Report 2024/25

Phase Holographic Imaging PHI
Selskabsmeddelelse26.9.2025, 09.03

Phase Holographic: Annual Report 2024/25

Phase Holographic Imaging PHI
Selskabsmeddelelse26.9.2025, 09.00

Phase Holographic: Interim Report 1 2025/26

Phase Holographic Imaging PHI
Pressemeddelelse9.9.2025, 09.38

BioStock: PHI strengthens presence in Asia through Gaia Bioscience

Phase Holographic Imaging PHI
Selskabsmeddelelse8.9.2025, 12.24

Phase Holographic: PHI provides an update regarding the development progress of the new generation of HoloMonitor®

Phase Holographic Imaging PHI
Pressemeddelelse2.9.2025, 10.24

Phase Holographic Imaging Signs New Distributor for Singapore and Malaysia

Phase Holographic Imaging PHI
Pressemeddelelse21.8.2025, 06.38

BioStock: PHI: "New distribution structure will position us to give greater value to clients"

Phase Holographic Imaging PHI
Pressemeddelelse15.7.2025, 10.10

BioStock: Green light for PHI to gear up its commercial strategy

Phase Holographic Imaging PHI
Selskabsmeddelelse26.6.2025, 10.26

Phase Holographic: Year-end report 2024/25

Phase Holographic Imaging PHI
Pressemeddelelse26.6.2025, 06.30

Phase Holographic: PHASE HOLOGRAPHIC IMAGING PHI Announces Key Organisational Changes

Phase Holographic Imaging PHI
Pressemeddelelse25.6.2025, 11.24

BioStock: PHI’s CEO comments on the proposed new distribution strategy

Phase Holographic Imaging PHI
Selskabsmeddelelse17.6.2025, 13.07

Phase Holographic: Proposal to amend the Altium Distribution Agreement

Phase Holographic Imaging PHI
Pressemeddelelse30.5.2025, 08.52

BioStock: New chapter at PHI as Eschricht resumes CEO role

Phase Holographic Imaging PHI
Selskabsmeddelelse23.5.2025, 12.25

Phase Holographic: Sales summary and profit warning for the fiscal year 2024/2025

Phase Holographic Imaging PHI
Selskabsmeddelelse21.5.2025, 09.12

Phase Holographic: PHI has appointed Patrik Eschricht as new CEO

Phase Holographic Imaging PHI
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.